MedTrace Logo

Transcatheter Aortic Valve Replacement in Severe Low Flow, Low Gradient Aortic Stenosis

NCT06589063 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1350

Last updated 2026-04-07

No results posted yet for this study

Summary

LOW-TAVR is a real-world, retrospective and prospective, multicenter Italian registry aimed at evaluating the characteristics and clinical outcomes of patients with severe low flow, low gradient aortic stenosis undergoing transcatheter aortic valve replacement (TAVR) and, in particular:

* risk factors
* gender differences
* comorbidities
* pharmacological treatment
* TAVR procedural characteristics
* periprocedural and in-hospital complications
* clinical outcome at 30-day, 1-year, 2-year and 5-year follow-up

Conditions

  • Low Flow, Low Gradient Aortic Stenosis

Interventions

DEVICE

Transcatheter aortic valve replacement

Transcatheter aortic valve replacement with implantation of new-generation balloon-expandable or self-expandable bioprostheses

Sponsors & Collaborators

  • University of Salerno

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2025-09-01
Completion
2037-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06589063 on ClinicalTrials.gov